The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency
- Resource Type
- Source
- Cellular & molecular immunology, 18(12):26732675
Cellular and Molecular Immunology - Subject
2019-20 coronavirus outbreak COVID-19 Vaccines Coronavirus disease 2019 (COVID-19) Infection Antibodies SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Immunology Spike Protein Virus Internalization Biology Antibodies, Viral Antibodies, Neutralizing Virology Cell Line Infectious Diseases Mutation Spike Glycoprotein, Coronavirus Correspondence biology.protein Humans Immunology and Allergy ddc:610 Antibody - Language
- English